Searched for
PROPRIETARY TRADING
BSE shares tumble 5% after Jefferies downgrades stock to 'underperform'. Here’s whyBSE shares fell sharply on Monday after Jefferies downgraded the stock and cut its target price to Rs 2,940, citing risks from proprietary ...
One common stock across 6 top performing mutual funds: Is MCX a signal or a crowded trade?MCX is the sole stock held by six top-performing mid and small-cap mutual funds. Analysts at UBS see a re-rating opportunity, upgrading the...
US to tell partners they must pick sides in AI race with ChinaBy pressing countries to choose sides the US hopes to starve China of resources in a race to make the most sophisticated AI, which could be...
For long-term investors, looking beyond the obvious: 5 large-cap stocks from different sectors with upside potential of up to 24%An investor looking for a sound company often looks for two obvious moats: Price and margin. But there is another one that rewards close sc...
Apple trains its own AI model for China market with Alibaba's supportThe AI model was developed in partnership with Alibaba Group and trained with the Chinese tech giant's support, the people said, declining ...
Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check statusMolbio Diagnostics IPO allotment is expected on Thursday after the Rs 939.70-crore issue was subscribed 70.26 times. With a grey market pre...
Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?Molbio Diagnostics IPO: Point-of-care molecular diagnostics company Molbio Diagnostics saw strong investor response for its IPO, drawing as...
Sebi proposes to allow FPIs to participate in physically settled commodity derivativesSebi plans to permit Foreign Portfolio Investors in physically settled commodity derivatives. This move aims to boost institutional partici...
- Molbio Diagnostics IPO Day 2: GMP hits at 17% listing gains. Should you bid?
Molbio Diagnostics IPO GMP: The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GM...
Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...
CAS is here to stay: SEBI confident that Closing Auction Session will improve as participation rises, despite market-wide confusionThe Securities and Exchange Board of India (Sebi) remains steadfast in its support for the newly implemented closing auction system. Despit...
CAS Chaos: Dalal Street's biggest stock trading reform in years endures a rocky first weekIndia's recently introduced closing auction system for stock prices is encountering early challenges, with traders raising alarms over erra...
Old strategies buried alive: How CAS hit Dalal Street tradersThe new closing auction session (CAS) has rattled Dalal Street, with traders saying long-standing strategies are no longer working. SEBI, h...
FPIs, trading companies tap Sebi, centre for tax breatherInvestors from abroad are pressing regulators for a decrease in securities transaction taxes to alleviate the burden of double capital gain...
Meta introduces Muse Code. It offers a 21x discount if you let it train on your dataMeta has introduced Muse Code, an advanced AI coding assistant aimed at software engineers. This innovative tool offers significant discoun...
ICAR develops indigenous African Swine Fever vaccine, strengthening India’s biosecurityDr. M.L. Jat, Secretary, DARE and Director General, ICAR said that this breakthrough marks the dawn of a new era in veterinary science.
Apple seeks preliminary injunction against OpenAI in trade secrets caseApple has requested a judge to prevent former employees and OpenAI from using confidential information. The tech giant is suing OpenAI and ...